Login/Sign Up
₹29855.4*
MRP ₹36409
18% off
₹30947.65*
MRP ₹36409
15% CB
₹5461.35 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Available Offers
Whats That
About Pamorelin La 22.5Mg Inj
Pamorelin La 22.5Mg Inj belongs to the class of 'anti-neoplastic agents', primarily used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.
Pamorelin La 22.5Mg Inj contains Triptorelin that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. The lowering of testosterone hormone levels in men helps slows down the growth of cancer cells in prostate cancer.
Use Pamorelin La 22.5Mg Inj as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Pamorelin La 22.5Mg Inj include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset stomach and swelling in legs. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Pamorelin La 22.5Mg Inj, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin La 22.5Mg Inj is not indicated for use in pregnant and breastfeeding women. Pamorelin La 22.5Mg Inj may make you feel dizzy, hence drive when you are alert only. Pamorelin La 22.5Mg Inj is not recommended for children below two years of age.
Uses of Pamorelin La 22.5Mg Inj
Directions for Use
Medicinal Benefits
Pamorelin La 22.5Mg Inj contains Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Pamorelin La 22.5Mg Inj is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Pamorelin La 22.5Mg Inj works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Pamorelin La 22.5Mg Inj reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis. Pamorelin La 22.5Mg Inj also has the role of a contraceptive drug.
How Pamorelin La 22.5Mg Inj Works
Storage
What if I have taken an overdose of Pamorelin La 22.5Mg Inj
Drug Warnings
Inform your doctor if you have any allergic reactions to Pamorelin La 22.5Mg Inj or other medications. Before starting Pamorelin La 22.5Mg Inj, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin La 22.5Mg Inj may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Pamorelin La 22.5Mg Inj. Pamorelin La 22.5Mg Inj can affect the unborn baby when used in pregnancy. Hence, Pamorelin La 22.5Mg Inj is not indicated for use in pregnancy and breastfeeding women. If you are using Pamorelin La 22.5Mg Inj, make sure to use reliable forms of contraception to prevent pregnancy during the course. Pamorelin La 22.5Mg Inj may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Pamorelin La 22.5Mg Inj can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Pamorelin La 22.5Mg Inj is not recommended for children younger than two years of age.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
It is advised to avoid alcohol consumption to minimize the unwanted effects of Pamorelin La 22.5Mg Inj. Please consult your doctor for more information.
Pregnancy
Unsafe
Pamorelin La 22.5Mg Inj is a pregnancy category X drug. It is unsafe to use Pamorelin La 22.5Mg Inj in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Pamorelin La 22.5Mg Inj.
Breast Feeding
Unsafe
Pamorelin La 22.5Mg Inj is unsafe to use during breastfeeding. Consult your doctor for further information.
Driving
Unsafe
Pamorelin La 22.5Mg Inj causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Pamorelin La 22.5Mg Inj.
Liver
Caution
Please let your doctor know if you have any history of liver diseases or hepatic impairment before starting Pamorelin La 22.5Mg Inj.
Kidney
Caution
Please let your doctor know if you have any history of kidney diseases before starting Pamorelin La 22.5Mg Inj.
Children
Caution
Pamorelin La 22.5Mg Inj is not recommended in children younger than two years of age.
Pamorelin La 22.5Mg Inj is used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children.
Pamorelin La 22.5Mg Inj contains Triptorelin, a synthetic hormone. It helps reduce the testosterone and oestrogen hormones in men and women, respectively. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis in women.
Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.
Pamorelin La 22.5Mg Inj should be used with caution and under doctor's supervision only if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Let your doctor know if you have any other medical concerns before using Pamorelin La 22.5Mg Inj.
During treatment with Pamorelin La 22.5Mg Inj in the first few weeks, a temporary increase in hormones may occur before they decrease. This may cause new or worsening of side effects of Pamorelin La 22.5Mg Inj. This is a normal response of your body to Pamorelin La 22.5Mg Inj. However, if you notice any symptoms that are not manageable, please seek medical advice.
Pamorelin La 22.5Mg Inj may worsen your mood disorders like depression. Hence it is advised to use Pamorelin La 22.5Mg Inj only when you are free from any kind of mental problems. Please consult your doctor for more information.
Pamorelin La 22.5Mg Inj may cause impotence and affect fertility in men. It is advised to speak to your doctor if you plan to have a family in the future before starting Pamorelin La 22.5Mg Inj.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information